Microbial Genomics and Drug Discovery
Editat de Thomas J. Dougherty, Steven J. Projanen Limba Engleză Hardback – 14 mai 2003
Preț: 1344.54 lei
Preț vechi: 1818.71 lei
-26% Nou
Puncte Express: 2017
Preț estimativ în valută:
257.34€ • 269.98$ • 213.48£
257.34€ • 269.98$ • 213.48£
Comandă specială
Livrare economică 08-22 ianuarie 25
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780824740412
ISBN-10: 0824740416
Pagini: 264
Dimensiuni: 152 x 229 x 18 mm
Greutate: 0.45 kg
Ediția:New.
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States
ISBN-10: 0824740416
Pagini: 264
Dimensiuni: 152 x 229 x 18 mm
Greutate: 0.45 kg
Ediția:New.
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States
Public țintă
ProfessionalCuprins
1. Global Aspects of Antibiotic Resistance 2. Genomics of Bacterial Pathogens 3. Bioinformatics, Genomics, and Antimicrobial Drug Discovery 4. The Pathway Tools Software and Its Role in Antimicrobial Drug Discovery 5. Genomic Strategies in Antibacterial Drug Discovery 6. Genomics-Based Approaches to Novel Antimicrobial Target Discovery 7. Pathogenesis Genes as Novel Targets 8. Application of Genomics to the Discovery of New Drugs Against Tuberculosis 9. Phenotype MicroArrays: Their Use in Antibiotic Discovery 10. Microbial Proteomics: New Approaches for Therapeutic Vaccines and Drug Discovery 11. Surrogate Ligand-Based Assay Systems for Discovery of Antibacterial Agents for Genomic Targets 12. Expression Profiling Uses in Antibacterial Chemotherapy Development 13. Using Fungal Genomes for the Discovery, Development, and Clinical Application of Novel and Current Antifungal Therapeutics 14. Genomics in Novel Natural Products Generation
Notă biografică
Dougherty\, Thomas J.; Projan\, Steven J.
Descriere
This book presents a broad range of microbial genomics-based approaches to the problem of identifying novel antibiotic classes, focusing on different aspects of the problems presented in identifying, selecting, and prosecuting novel antibacterial targets.